Categories: Health

Study: More than 99% of drug trials for Alzheimer’s disease failed

More than 99 percent of drug trials for Alzheimer's disease during the past decade have failed

According to a US study, more than 99% of drug trials for Alzheimer’s disease during the past decade have failed.

There is an urgent need to increase the number of potential therapies being investigated, say US scientists.

More than 99 percent of drug trials for Alzheimer’s disease during the past decade have failed

Only one new medicine has been approved since 2004, they report in the journal Alzheimer’s Research & Therapy.

Dr. Jeffrey Cummings, of the Cleveland Clinic Lou Ruvo Center for Brain Health, in Las Vegas, and colleagues, examined a public website that records clinical trials.

Between 2002 and 2012, they found 99.6% of trials of drugs aimed at preventing, curing or improving the symptoms of Alzheimer’s had failed or been discontinued.

This compares with a failure rate of 81% for cancer drugs.

Alzheimer’s disease is the most common form of dementia.

z7D1pDfr7No

Kathryn R. Bown

Kathryn - Our health specialist likes to share with the readers the latest news from the field. Nobody understands better than her the relation between healthy mind and healthy body.